Health · the U.S. · October 16, 2026
From CBS News
The providers of Clairity Breast, a new FDA-approved AI tool, claim their tech provides an accurate five-year risk assessment for breast cancer, for just $249. Dr. Céline Gounder shares her thoughts.
Reported by CBS News, October 16, 2026. Read the full story at CBS News →